ArticleBMC public health2025
The burden of disease attributable to high body mass index across Arab countries: an analysis of data from the global burden of disease study 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOverweight and obesity are major risk factors for numerous communicable and non-communicable health conditions. Some of those diseases which can be prevented are cardiovascular diseases, diabetes, and chronic kidney disease. In Arab countries, prevalence of overweight and obesity is double what it is globally, making obesity a top public health concern. This study seeks to investigate the regional burden of high BMI-attributable disease and compare it with global data, to shed light on this public health issue and inform future policies.
methodsData from the Global Burden of Disease (GBD) Study 2021, including global and Arab countries statistics, were systematically extracted and analysed. A high body mass index (BMI) was defined as a value of 25 kg/m² or greater. Trends for nine major causes of high BMI-attributable deaths, disability-adjusted life years (DALYs), and years of life lost from mortality (YLLs) were analysed by age and sex, from 1990 to 2021.
resultsIn Arab countries, the top causes of high BMI-attributable age-standardised deaths, DALYs, and YLLs in 2021 were cardiovascular diseases, diabetes and kidney diseases, and neoplasms (replacing chronic respiratory diseases in 1990). There was a notable increase in the disease burden attributable to high BMI between 1990 and 2021, with a consistently higher burden compared to global data. Mortality caused by cardiovascular diseases and diabetes and kidney diseases in Arab countries was higher in females than males, compared to global mortality data.
conclusionsThe considerable disease burden attributable to high BMI in Arab countries highlights the necessity for integrated, population-level interventions aimed at holistically preventing high BMI in this region. Longitudinal and qualitative research on perceptions and drivers of trends in high BMI within Arab countries are necessary to gain context and add to the evidence base, allowing for the development of suitable and effective interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.